ENSC
ENSC
NASDAQ · Biotechnology

Ensysce Biosciences Inc

$0.35
-0.05 (-12.59%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +10,801.0% upside
Low Target $25.94
Average Target $37.99
High Target $62.46
Current Price $0.35
Current
$0.35
Target
$37.99
$25.94 $37.99 avg $62.46
Scenario Analysis
Bear Case
$25.94
7,343.3%
Low target
Base Case
$37.99
+10,801.0%
Avg target
Bull Case
$62.46
+17,822.5%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$2.75
-87.3% from high
52-Week Low
$0.23
+51.5% from low
Target vs 52W High
$37.99
+1,281.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +2.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -15.1%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.5%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.6%